Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
GENELINK INC (GNLK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2009 |
8-K
| Form 8-K - Current report |
| 08/19/2009 |
8-K
| Form 8-K - Current report |
| 07/06/2009 |
8-K
| Appointed a new director|
Docs:
|
"GeneLink BioSciences, Inc. Names James Antal to Board of Directors Orlando, Florida - July 6, 2009 - GeneLink BioSciences, Inc. , has appointed James Antal to the Company's Board of Directors. Mr. Antal brings decades of financial and management experience to GeneLink and will serve as Chairman of the Audit Committee. “On behalf of GeneLink BioSciences, I would like to welcome Jim to the Board of Directors,” said Dr. Bernard Kasten, Executive Chairman. “We look forward to working with Jim as we focus on fully realizing the benefits of the tremendous opportunities available to GeneLink. Jim's financial and biotech experience will be an asset to GeneLink and its shareholders.” Mr. Antal is a member of the board of directors of Cleveland Biolabs, Inc. and SIGA Technologies, Inc. , biotechnolo..." |
|
| 06/14/2006 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Secu... |
| 08/01/2005 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers |
|
|